| Dysregulation of muscle cholesterol transport in amyotrophic lateral sclerosis D Sapaly, F Cheguillaume, L Weill, Z Clerc, O Biondi, S Bendris, C Buon, ... Brain, awae270, 2024 | | 2024 |
| Muscle involvement in systemic sclerosis: high mortality not associated with nature of histological lesions N Le Gouellec, L Zaidan, B Chaigne, B Periou, E Cailliau, R Dhote, ... Rheumatology, keae407, 2024 | | 2024 |
| Widespread Myalgia and Chronic Fatigue: Phagocytes from Macrophagic Myofasciitis Patients Exposed to Aluminum Oxyhydroxide-Adjuvanted Vaccine Exhibit Specific Inflammatory … JD Masson, G Badran, RK Gherardi, FJ Authier, G Crépeaux Toxics 12 (7), 491, 2024 | | 2024 |
| Atteinte musculaire au cours de la sclérodermie systémique: la mortalité n’est pas associée à la nature des lésions histologiques N Le Gouellec, L Zaidan, B Chaigne, B Periou, E Cailliau, R Dhôte, ... La Revue de Médecine Interne 45, A58, 2024 | | 2024 |
| Rhabdomyolyse induite par l’examen clinique S Souvannanorath, FJ Authier Revue Neurologique 180, S124, 2024 | | 2024 |
| An up-to-date myopathologic characterisation of facioscapulohumeral muscular dystrophy type 1 muscle biopsies shows sarcolemmal complement membrane attack complex deposits and … L Hubregtse, K Bouman, C Lama, S Lassche, N de Graaf, V Taglietti, ... Neuromuscular Disorders 36, 6-15, 2024 | | 2024 |
| Characterizing acute-onset small fiber neuropathy T Gendre, JP Lefaucheur, T Nordine, Y Baba-Amer, FJ Authier, J Devaux, ... Neurology: Neuroimmunology & Neuroinflammation 11 (2), e200195, 2024 | 4 | 2024 |
| L’expression myocytaire de MHC-2 est un biomarqueur de myosite de chevauchement et de myosite à inclusions C Hou, J Aouizerate, YB Amer, E Malfatti, L Martin, J Authier Morphologie 107 (359), 100639, 2023 | | 2023 |
| Interferon-gamma-mediated JAK/STAT1 signalling triggers muscle damage in Inclusion Body Myositis C Hou, B Periou, M Gervais, J Berthier, YB Amer, E Malfatti, ... Morphologie 107 (359), 100625, 2023 | | 2023 |
| Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature J Demortier, M Vautier, O Chosidow, L Gallay, D Bessis, A Berezne, ... Rheumatology 62 (12), 3932-3939, 2023 | 8 | 2023 |
| Receptor interacting protein kinase‐3 mediates both myopathy and cardiomyopathy in preclinical animal models of Duchenne muscular dystrophy M Bencze, B Periou, I Punzón, I Barthélémy, V Taglietti, C Hou, L Zaidan, ... Journal of Cachexia, Sarcopenia and Muscle 14 (6), 2520-2531, 2023 | 1 | 2023 |
| Loss of phospholipase PLAAT3 causes a mixed lipodystrophic and neurological syndrome due to impaired PPARγ signaling N Schuermans, S El Chehadeh, D Hemelsoet, J Gautheron, ... Nature genetics 55 (11), 1929-1940, 2023 | 7 | 2023 |
| Myopathologic trajectory in Duchenne muscular dystrophy (DMD) reveals lack of regeneration due to senescence in satellite cells N Cardone, V Taglietti, S Baratto, K Kefi, B Periou, C Gitiaux, C Barnerias, ... Acta Neuropathologica Communications 11 (1), 167, 2023 | 9 | 2023 |
| Myalgic encephalomyelitis/chronic fatigue syndrome: Presentation, cognitive profile, and support perspectives MA Sebaiti, Y Gounden, FJ Authier, M Hainselin Revue de neuropsychologie 15 (4), 247-257, 2023 | | 2023 |
| An early onset benign myopathy with glycogen storage caused by a de novo 1.4 Mb-deletion of chromosome 14 G Severa, A Pennisi, C Barnerias, C Fiorillo, M Scala, V Taglietti, ... Neuromuscular Disorders 33 (10), 817-821, 2023 | | 2023 |
| P342 An early onset benign myopathy with glycogen storage caused by a de novo 1.3 microdeletion of chromosome 14 G Severa, C Fiorillo, M Scala, V Taglietti, A Cojocaru, G Tachdjian, ... Neuromuscular Disorders 33, S180-S181, 2023 | | 2023 |
| Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in France T Damy, A Zaroui, M de Tournemire, M Kharoubi, R Gounot, A Galat, ... Archives of cardiovascular diseases 116 (10), 433-446, 2023 | 2 | 2023 |
| Dysferlinopathy in Tunisia: clinical spectrum, genetic background and prognostic profile I Belhassen, S Laroussi, S Sakka, S Rekik, L Lahkim, M Dammak, ... Neuromuscular Disorders 33 (10), 718-727, 2023 | | 2023 |
| Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds to pharmacological inhibition C Bayard, E Segna, M Taverne, A Fraissenon, Q Hennocq, B Periou, ... Journal of Experimental Medicine 220 (11), e20230926, 2023 | 3 | 2023 |
| Revisiting idiopathic eosinophilic myositis: towards a clinical-pathological continuum from the muscle to the fascia and skin C Fermon, LER Lessard, T Fenouil, A Meyer, M Faruch-Bilfeld, M Robert, ... Rheumatology 62 (6), 2220-2229, 2023 | 2 | 2023 |
